Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gil-Vernet

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Transplantation Proceedings|January 3, 2006
Clinical and virological effects during two years of ongoing adefovir dipivoxil in the treatment of lamivudine-resistant chronic hepatitis B infectionJ B Gornals, T Casanovas, M Sabidó, et al.
Transplantation|June 15, 1997
Steroid withdrawal in mycophenolate mofetil-treated renal allograft recipientsJ M Grinyo, S Gil-Vernet, D Serón, et al.
Antimicrobial Agents and Chemotherapy|September 10, 2009
Population pharmacokinetics of ganciclovir after intravenous ganciclovir and oral valganciclovir administration in solid organ transplant patients infected with cytomegalovirusA Caldés, H Colom, Y Armendariz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1992
Antilymphocyte globulin versus OKT3 induction therapy in cadaveric kidney transplantation: a prospective randomized studyJ M Grino, A M Castelao, D Serón, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 17, 2009
Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokineticsA Caldés, S Gil-Vernet, Y Armendariz, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 17, 2006
Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft lossF Moreso, M Ibernon, M Gomà, et al.
Transplantation Proceedings|September 29, 1999
Double kidney transplantL Riera, D Serón, E Franco, et al.
Transplantation Proceedings|August 1, 1995
Interferon may be useful in hemodialysis patients with hepatitis C virus chronic infection who are candidates for kidney transplantT Casanovas Taltavull, C Baliellas, E Sesé, et al.
Transplantation Proceedings|August 1, 1995
Multivariate analysis of prognostic factors in renal transplantationF Moreso, M Gallén, R García-Osuna, et al.
Transplantation Proceedings|October 1, 1995
Long-term follow up of transplanted non-heart-beating donor kidneysC González Segura, A M Castelao, J Torras, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Transplantation Proceedings|January 3, 2006
Clinical and virological effects during two years of ongoing adefovir dipivoxil in the treatment of lamivudine-resistant chronic hepatitis B infectionJ B Gornals, T Casanovas, M Sabidó, et al.
Transplantation|June 15, 1997
Steroid withdrawal in mycophenolate mofetil-treated renal allograft recipientsJ M Grinyo, S Gil-Vernet, D Serón, et al.
Antimicrobial Agents and Chemotherapy|September 10, 2009
Population pharmacokinetics of ganciclovir after intravenous ganciclovir and oral valganciclovir administration in solid organ transplant patients infected with cytomegalovirusA Caldés, H Colom, Y Armendariz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1992
Antilymphocyte globulin versus OKT3 induction therapy in cadaveric kidney transplantation: a prospective randomized studyJ M Grino, A M Castelao, D Serón, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 17, 2009
Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokineticsA Caldés, S Gil-Vernet, Y Armendariz, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 17, 2006
Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft lossF Moreso, M Ibernon, M Gomà, et al.
Transplantation Proceedings|September 29, 1999
Double kidney transplantL Riera, D Serón, E Franco, et al.
Transplantation Proceedings|August 1, 1995
Interferon may be useful in hemodialysis patients with hepatitis C virus chronic infection who are candidates for kidney transplantT Casanovas Taltavull, C Baliellas, E Sesé, et al.
Transplantation Proceedings|August 1, 1995
Multivariate analysis of prognostic factors in renal transplantationF Moreso, M Gallén, R García-Osuna, et al.
Transplantation Proceedings|October 1, 1995
Long-term follow up of transplanted non-heart-beating donor kidneysC González Segura, A M Castelao, J Torras, et al.
Pageof 8